Sirenas Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Debt - PPP
- Investors
-
4
Sirenas General Information
Description
Developer of marine-inspired drug discovery platform designed to treat cancer and infectious diseases. The company's platform offers an online platform to uncover the therapeutic potential of nature's chemistry by using big data mining and deep learning approaches to continuously interrogate the relationships between millions of natural small molecule metabolites and disease-relevant biological models, enabling researchers to focus on the discovery and development of novel and differentiated payloads for oncology antibody-drug conjugates (ADCs).
Contact Information
Website
www.sirenasmd.comCorporate Office
- 3550 General Atomics Court
- San Diego, CA 92121
- United States
Corporate Office
- 3550 General Atomics Court
- San Diego, CA 92121
- United States
Sirenas Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Debt - PPP | 15-Apr-2020 | Completed | Startup | |||
4. Grant | 03-Oct-2016 | Completed | Startup | |||
3. Accelerator/Incubator | 10-Jun-2015 | Completed | Startup | |||
2. Seed Round | 22-Apr-2014 | $1.32M | $1.32M | Completed | Startup | |
1. Grant | 24-Feb-2014 | $293K | Completed | Startup |
Sirenas Comparisons
Industry
Financing
Details
Sirenas Competitors (38)
One of Sirenas’s 38 competitors is BioLegend, a Formerly Accelerator/Incubator backed company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
Compass Therapeutics | Formerly VC-backed | Boston, MA | ||||
Byondis | Corporation | Nijmegen, Netherlands | ||||
CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
Amunix Pharmaceuticals | Formerly PE-Backed | South San Francisco, CA |
Sirenas Signals
Sirenas Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | |||
Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | Minority | ||
National Institute Of Allergy and Infectious Diseases | Government | |||
U.S. Department of Health and Human Services | Government |
Sirenas FAQs
-
When was Sirenas founded?
Sirenas was founded in 2011.
-
Where is Sirenas headquartered?
Sirenas is headquartered in San Diego, CA.
-
What is the size of Sirenas?
Sirenas has 13 total employees.
-
What industry is Sirenas in?
Sirenas’s primary industry is Biotechnology.
-
Is Sirenas a private or public company?
Sirenas is a Private company.
-
What is Sirenas’s current revenue?
The current revenue for Sirenas is
. -
How much funding has Sirenas raised over time?
Sirenas has raised $1.32M.
-
Who are Sirenas’s investors?
Bill & Melinda Gates Foundation, Johnson & Johnson Innovation - JLABS, National Institute Of Allergy and Infectious Diseases, and U.S. Department of Health and Human Services have invested in Sirenas.
-
Who are Sirenas’s competitors?
BioLegend, Compass Therapeutics, Byondis, CytomX Therapeutics, and Amunix Pharmaceuticals are some of the 38 competitors of Sirenas.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »